- Forums
- ASX - By Stock
- ACW
- Ann: Positive Xanamem biomarker trial published in Jnl Alz Dis
Ann: Positive Xanamem biomarker trial published in Jnl Alz Dis, page-34
-
-
- There are more pages in this discussion • 55 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add ACW (ASX) to my watchlist
|
|||||
Last
2.7¢ |
Change
0.002(8.00%) |
Mkt cap ! $73.21M |
Open | High | Low | Value | Volume |
2.6¢ | 2.8¢ | 2.5¢ | $243.1K | 9.047M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
17 | 3223180 | 2.6¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
2.7¢ | 1163005 | 4 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
17 | 3223180 | 0.026 |
33 | 5161667 | 0.025 |
10 | 1793861 | 0.024 |
9 | 1048348 | 0.023 |
6 | 1863300 | 0.022 |
Price($) | Vol. | No. |
---|---|---|
0.027 | 1163550 | 4 |
0.028 | 1945223 | 11 |
0.029 | 1250877 | 14 |
0.030 | 2089017 | 9 |
0.031 | 830000 | 6 |
Last trade - 14.58pm 15/08/2024 (20 minute delay) ? |
Featured News
ACW (ASX) Chart |
The Watchlist
I88
INFINI RESOURCES LIMITED
Charles Armstrong, CEO & Managing Director
Charles Armstrong
CEO & Managing Director
SPONSORED BY The Market Online